Literature DB >> 1878281

Reduced hepatic iron uptake from rat aglycotransferrin.

W L Hu1, P A Chindemi, E Regoeczi.   

Abstract

Rat aglycotransferrin (rAgTf) was produced from the disialosyl diantennary fraction of rat transferrin (rTf) by treatment with peptide: N-glycosidase F. Following removal of the enzyme by gel filtration and isolation of the deglycosylated protein by lectin chromatography, rAgTf was compared to rTf both in vitro and in vivo. No significant differences were found between the two proteins with respect to affinity for iron and kinetics of Fe release from the N-lobe and C-lobe. The fluorescence emission spectrum of apo-rTf was red-shifted by approximately 3 nm relative to diferric rTf; however, no spectral difference was detected between rTf and rAgTf when the analogous forms (apo or diferric) were compared. Plasma clearance of radioactive iron administered to rats as either rTf or rAgTf was comparable. Reticulocytes took up iron from rAgTf slightly faster than from rTf. In contrast, Fe acquisition by the liver from rAgTf was significantly reduced relative to rTf. This finding contrasts sharply with earlier observations with asialotransferrin (rAsTf) and provides a basis for discounting charge loss as the mechanism of enhanced hepatic Fe uptake from rAsTf. It is suggested that the glycan complement of rTf, while unimportant for interaction of the protein with specific receptors, probably plays a role in the interaction with low-affinity hepatic binding sites.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1878281     DOI: 10.1007/bf01135384

Source DB:  PubMed          Journal:  Biol Met        ISSN: 0933-5854


  23 in total

1.  The chromatographic heterogeneity of rat transferrin on immobilized concanavalin A and lentil lectin.

Authors:  E Regoeczi; P A Chindemi; J R Rudolph; G Spik; J Montreuil
Journal:  Biochem Cell Biol       Date:  1987-11       Impact factor: 3.626

Review 2.  Role of transferrin receptors and endocytosis in iron uptake by hepatic and erythroid cells.

Authors:  E H Morgan; E Baker
Journal:  Ann N Y Acad Sci       Date:  1988       Impact factor: 5.691

3.  Comparison of the sedimentation and gel-filtration behaviour of human apotransferrin and its copper and iron complexes.

Authors:  P A Charlwood
Journal:  Biochem J       Date:  1973-08       Impact factor: 3.857

4.  Citrate-mediated exchange of FE3+ among tranferrin molecules.

Authors:  P Aisen
Journal:  Biochem Biophys Res Commun       Date:  1968-07-26       Impact factor: 3.575

5.  Transferrin binding and iron uptake in mouse hepatocytes.

Authors:  E S Cole; J Glass
Journal:  Biochim Biophys Acta       Date:  1983-02-16

6.  Preferential hepatic uptake of iron from rat asialotransferrin: possible engagement of two receptors.

Authors:  J R Rudolph; E Regoeczi; P A Chindemi; M T Debanne
Journal:  Am J Physiol       Date:  1986-09

7.  Transferrin uptake and release by reticulocytes treated with proteolytic enzymes and neuraminidase.

Authors:  D Hemmaplardh; E H Morgan
Journal:  Biochim Biophys Acta       Date:  1976-03-19

8.  Transferrin protein and iron uptake by cultured hepatocytes.

Authors:  J C Sibille; J N Octave; Y J Schneider; A Trouet; R R Crichton
Journal:  FEBS Lett       Date:  1982-12-27       Impact factor: 4.124

9.  Transferrin receptors and the uptake and release of iron by isolated hepatocytes.

Authors:  S P Young; P Aisen
Journal:  Hepatology       Date:  1981 Mar-Apr       Impact factor: 17.425

Review 10.  Current ideas on the significance of protein glycosylation.

Authors:  C M West
Journal:  Mol Cell Biochem       Date:  1986 Nov-Dec       Impact factor: 3.396

View more
  2 in total

Review 1.  Known and potential roles of transferrin in iron biology.

Authors:  Thomas Benedict Bartnikas
Journal:  Biometals       Date:  2012-08       Impact factor: 2.949

2.  Influence of transferrin glycans on receptor binding and iron-donation.

Authors:  P Hoefkens; M I Huijskes-Heins; C M de Jeu-Jaspars; W L van Noort; H G van Eijk
Journal:  Glycoconj J       Date:  1997-02       Impact factor: 2.916

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.